COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110104100A1
SERIAL NO

12681600

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods, compositions of matter, and cells, useful for the treatment of autism, social integrative disorders, and various cognitive abnormalities. The invention discloses, inter alia, means of substantially ameliorating or reversing the progression of autism through the administration of autologous and/or allogeneic stem cells, alone or in combination with mobilization agents. The use of stem cells and cells naturally possessing or endowed with angiogenic and anti-inflammatory activity are disclosed for autism either alone or in combination with various therapeutic interventions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
XON CELLS, INC.GERMANTOWN, MD4

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ichim, Thomas E San Diego, US 27 187
Riordan, Neil H Tempe, US 35 183

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Medistem Labortories (1)
* 2008/0254,005 Stem Cell Therapy for the Treatment of Autism and Other Disorders 10 2008
 
Other [Check patent profile for assignment information] (3)
* 2002/0013,270 Method for treating a mental disorder 20 2001
* 2003/0191,061 Treatment methods using homeopathic preparations of growth factors 17 2002
* 2007/0142,745 Method of procuring birth tissue 0 2005
 
OSINIS THERAPEUTICS, INC. (1)
* 2005/0239,897 Mesenchymal stem cells and uses therefor 45 2005
 
FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE (1)
* 2004/0018,617 Somatic pluripotent cells 38 2002
 
SMITH & NEPHEW, INC. (1)
* 5902741 Three-dimensional cartilage cultures 182 1995
 
KATHOLIEKE UNIVERSITEIT LEUVEN (1)
* 2008/0064,038 Autism Genes and Regulated Secretion 1 2005
 
UNIVERSITE LOUIS PASTEUR (1)
* 2007/0105,946 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics 0 2004
 
HENRY FORD HEALTH SYSTEM (1)
* 2005/0143,388 Nitric oxide donors for treatment of disease and injury 2 2004
 
CHILDREN'S MEDICAL CENTER CORPORATION (1)
* 2009/0176,226 METHOD FOR DIAGNOSING AUTISM SPECTRUM DISORDER 2 2008
 
NORTHWESTERN UNIVERSITY (1)
* 2005/0089,507 G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction 0 2003
 
OSAKA UNIVERSITY (1)
* 2009/0118,179 Therapeutic Agent for Dentin-Pulp Complex Regeneration 0 2006
 
SCHERING AKTIENGESELLSCHAFT (1)
* 2002/0006,948 1,2 diarylbenzimdazoles and their pharmaceutical use 2 2001
 
FOREST LABORATORIES HOLDINGS LIMITED (1)
* 2008/0108,643 METHOD FOR TREATING AUTISM 4 2007
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
ALLOSOURCE (4)
9358320 Multi-layer tissue patches 2 2011
9480549 Multi-layer tissue patches 0 2013
9616152 Multi-layer tissue systems and methods 0 2013
9446077 Fascia fibrous compositions and methods for their use and manufacture 0 2014
 
MESOBLAST, INC. (2)
* 9487756 Production of reprogrammed pluripotent cells 0 2010
* 2012/0121,548 PRODUCTION OF REPROGRAMMED PLURIPOTENT CELLS 0 2010
 
Research Cancer Institute of America (2)
8933078 Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances 0 2011
9364500 Compositions for treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances 0 2014
* Cited By Examiner